Cerebra Network for Neurodevelopmental Disorders: New Collaborative Research Network Investigates Rare Disorders
Sourced from publicdomainpictures.net (https://www.publicdomainpictures.net/en/view-image.php?image=275669&picture=chemical-research)

Cerebra Network for Neurodevelopmental Disorders: New Collaborative Research Network Investigates Rare Disorders

Rare disease research faces many obstacles: lack of participants, lack of funding, and lack of interest are just a few. Now, the charity Cerebra has launched a network to take…

Continue Reading Cerebra Network for Neurodevelopmental Disorders: New Collaborative Research Network Investigates Rare Disorders
Study Illuminates Impact of Aromatic L-Amino Acid Decarboxylase Deficiency on Caregivers
source: pixabay.com

Study Illuminates Impact of Aromatic L-Amino Acid Decarboxylase Deficiency on Caregivers

PTC Therapeutics has just announced data from the very first study which examined how taking care of a child diagnosed with aromatic L-amino acid decarboxylase (AADC) deficiency can impact caregivers.…

Continue Reading Study Illuminates Impact of Aromatic L-Amino Acid Decarboxylase Deficiency on Caregivers
The First Patient Has Been Dosed in a Trial for Glioblastoma, Medulloblastoma, and Ependymoma
source: pixabay.com

The First Patient Has Been Dosed in a Trial for Glioblastoma, Medulloblastoma, and Ependymoma

Mustang Bio, a biopharmaceutical company, and City of Hope, a cancer center, have just revealed that their first participant in their Phase 1 clinical trial for leptomeningeal brain tumors including…

Continue Reading The First Patient Has Been Dosed in a Trial for Glioblastoma, Medulloblastoma, and Ependymoma
Managing Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis
source: pixabay.com

Managing Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis

According to an article in Healio, Dr. Anisha Dua recently addressed attendees at the ACR Clinical Symposium on the subject of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Dr. Dua is the…

Continue Reading Managing Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis
Nivolumab and Ipilimumab as a Treatment for Malignant Pleural Mesothelioma
source: pixabay.com

Nivolumab and Ipilimumab as a Treatment for Malignant Pleural Mesothelioma

Based on new data, the European Medicines Agency’s Committee for Medicinal Products for Human Use has designated nivolumab and ipilimumab as the frontline treatment for malignant pleural mesothelioma (MPM) in…

Continue Reading Nivolumab and Ipilimumab as a Treatment for Malignant Pleural Mesothelioma
A Combination of Nucala and Corticosteroids Was Shown to Increase Remission in EGPA
qimono / Pixabay

A Combination of Nucala and Corticosteroids Was Shown to Increase Remission in EGPA

Corticosteroids are used to treat a wide variety of inflammatory conditions, with asthma and arthritis acting as examples. However, these drugs can result in a variety of side effects, such…

Continue Reading A Combination of Nucala and Corticosteroids Was Shown to Increase Remission in EGPA
Biogen’s Recent Progress in Relapsing Multiple Sclerosis Presented at the 2021 Meeting of the AAN
source: pixabay.com

Biogen’s Recent Progress in Relapsing Multiple Sclerosis Presented at the 2021 Meeting of the AAN

According to an article in Biospace, Biogen, a biotechnology company headquartered in Cambridge, Massachusetts, presented new data on its multiple sclerosis (MS) therapies at the virtual Meeting of the American…

Continue Reading Biogen’s Recent Progress in Relapsing Multiple Sclerosis Presented at the 2021 Meeting of the AAN

What Is The Best Treatment For Twin Anemia Polycythemia Sequence? A Look At The TAPS Trial

In 2006, a new, rare disease affecting monochorionic twins was identified and named. Twin Anemia Polycythemia Sequence (TAPS) changed the perception of the complications of monochorionic twins. It started redefining…

Continue Reading What Is The Best Treatment For Twin Anemia Polycythemia Sequence? A Look At The TAPS Trial

Humane Lab Testing in Dogs Leads to a Possible Cure for Leber Congenital Amaurosis (LCA) in Humans

Veterinary ophthalmologists at Pennsylvania’s Veterinarian School of Medicine found that LCA in humans mimics the same type of disease in dogs. According to a recent article in Science Daily, vision…

Continue Reading Humane Lab Testing in Dogs Leads to a Possible Cure for Leber Congenital Amaurosis (LCA) in Humans